Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis

J Am Acad Dermatol. 2014 Apr;70(4):621-629. doi: 10.1016/j.jaad.2014.01.857.

Abstract

Background: The role of human papillomavirus (HPV) in cutaneous squamous cell carcinoma (cuSCC) is not well defined, with past studies showing conflicting results.

Objective: We sought to determine if there is a significant association between HPV and cuSCC and whether cuSCC from immunosuppressed patients are more likely to carry HPV than cuSCC from immunocompetent patients.

Methods: We performed a systematic review and abstracted data from articles that included: skin samples by biopsy, HPV detection by polymerase chain reaction, and a minimum of 10 cases and 10 controls. Pooled effect size and 95% confidence intervals were calculated using random effects meta-analysis using the inverse variance method.

Results: cuSCC were more likely to carry HPV than normal-appearing skin (pooled effect size [ES] 3.43, 95% confidence interval 1.97-5.98, P < .0001) in all patients. An increase in HPV prevalence was found in tumors from immunosuppressed patients compared with immunocompetent patients (pooled ES 3.01, 95% confidence interval 2.00-4.52, P < .0001).

Limitations: The greatest limitation is the heterogeneity of the studies included. The association of higher HPV prevalence in squamous cell carcinoma compared with normal-appearing skin does not imply causality.

Conclusion: These results contribute to evidence that HPV is associated with cuSCC. Higher HPV burden in tumors from immunosuppressed patients compared with immunocompetent patients may have therapeutic implications.

Keywords: cutaneous squamous cell carcinoma; human papillomavirus; immunocompetence; immunosuppression; meta-analysis; skin cancer.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Biopsy, Needle
  • Carcinoma, Squamous Cell / epidemiology*
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / virology*
  • Case-Control Studies
  • Comorbidity
  • Humans
  • Immunocompetence
  • Immunocompromised Host
  • Immunohistochemistry
  • Neoplasm Staging
  • Papillomaviridae / immunology
  • Papillomaviridae / pathogenicity*
  • Papillomavirus Infections / diagnosis
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / immunology
  • Prevalence
  • Prognosis
  • Risk Assessment
  • Skin Neoplasms / epidemiology*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / virology*
  • Viral Load / immunology